ARK Investment Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,103
Closed -$3.69M 219
2019
Q3
$3.69M Sell
3,103
-5,261
-63% -$8.03M 0.08% 83
2019
Q2
$13.8M Sell
8,364
-3,641
-30% -$6.3M 0.35% 45
2019
Q1
$24.5M Sell
12,005
-3,199
-21% -$5.63M 0.7% 34
2018
Q4
$19.5M Sell
15,204
-15,726
-51% -$24.1M 0.79% 29
2018
Q3
$58.5M Buy
30,930
+10,602
+52% +$21.9M 1.77% 22
2018
Q2
$41.3M Buy
20,328
+5,089
+33% +$11.6M 1.51% 23
2018
Q1
$33.7M Buy
15,239
+5,862
+63% +$14.9M 1.67% 22
2017
Q4
$21.6M Sell
9,377
-1,009
-10% -$2.05M 1.72% 20
2017
Q3
$18.5M Buy
10,386
+1,146
+12% +$1.6M 2.26% 11
2017
Q2
$12.6M Buy
9,240
+2,858
+45% +$3.45M 2.45% 12
2017
Q1
$7.51M Buy
6,382
+542
+9% +$553K 2.17% 14
2016
Q4
$4.67M Buy
+5,840
New +$4.64M 1.7% 20

Other funds holding BLUE

ARK Investment Management's BLUE Position: Q4 2019 in Review

ARK Investment Management sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 3,103 shares — an estimated $3.69M sold.

ARK Investment Management first reported a position in BLUE in Q4 2016 and held it in 12 quarters. The position peaked at $58.5M in Q3 2018. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • ARK Investment Management reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
  • ARK Investment Management sold 3,103 bluebird bio shares in Q4 2019, an estimated $3.69M.
  • ARK Investment Management first reported a position in bluebird bio in Q4 2016 and held it in 12 quarters.
  • ARK Investment Management's bluebird bio position peaked at $58.5M in Q3 2018.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on ARK Investment Management's 13F filing for Q4 2019, filed 31 Jan 2020.